A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Conditions
Advanced Solid Tumors With KRAS G12C Mutations · Solid Tumor, Adult · Unresectable Solid Tumor · Metastatic Solid Tumor · Non Small Cell Lung Cancer · Colorectal Cancer · KRAS G12C · Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla, California, United States
University of California Irvine (UCI) - Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Florida Cancer Specialists and Research Institute, Lake Mary, Florida, United States
Northwest Cancer Centers, Dyer, Indiana, United States
The University of Kansas Cancer Center, Fairway, Kansas, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Program Manager) · jennifer.louie2@pennmedicine.upenn.edu · 267-414-6179The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Community Clinical Trials, Kingwood, Texas, United States
South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States
Contact: Study coordinator (Physician Referral Coordinator) · isabel.jimenez@startsa.com · 210-593-5265UT Health San Antonio, San Antonio, Texas, United States
START Mountain Region, West Valley City, Utah, United States
Contact: Study coordinator (Director, Clinical Operation) · marie.asay@startthecure.com · 801-907-4770Virginia Cancer Specialists, Fairfax, Virginia, United States
Contact: Study coordinator (Clinical Trials Nurse Navigator) · carrie.friedman@usoncology.com · 703-636-1473Macquarie University, Macquarie Park, New South Wales, Australia
Tasman Health Care, Southport, Queensland, Australia
Icon Cancer Centre Kurralta Park, Kurralta Park, South Australia, Australia
GenesisCare North Adelaide, North Adelaide, South Australia, Australia
Eastern Health - Box Hill Hospital, Box Hill, Victoria, Australia
Linear Clinical Research Ltd, Nedlands, Western Australia, Australia
Contact: Study coordinator (Head of Project Operations) · actcmanagement@linear.org.au · 61 (08) 6382 5100Seoul National University Hospital, Seoul, Jongno-gu, South Korea
Severance Hospital, Seoul, Seodaemun-gu, South Korea
Korea University Anam Hospital, Seoul, Seongbuk-gu, South Korea
Seoul National University Bundang Hospital, Gyeonggi-do, Seongnam-si, South Korea
The Catholic University of Korea, St. Vincent's Hospital, Gyeonggi-do, Suwon-si, South Korea
Study leads
Medical Lead
Study Director
Frontier Medicines Corporation